Skip to content

An expressive writing randomised controlled trial with colorectal cancer patients: A test of the underlying mechanism

A randomised controlled trial with curative colorectal cancer patients to test the effectiveness of an expressive writing intervention to improve psychological adjustment and lessen the physical symptoms resulting from cancer treatment

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000204549
Enrollment
160
Registered
2006-05-29
Start date
2006-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will test an expressive writing intervention with bowel cancer patients to determine whether participation in the intervention leads to improved physical functioning, lessened psychological distress and increased personal growth, compared to those who do not participate in the intervention. Expressive writing is the writing of deep thoughts and feelings connected to a person's cancer diagnosis and treatment experiences. Participants in the intervention group will write in a journal for 30 minutes, 4 times, over 3 weeks. Participants will fill out questionnaires before and after the intervention as well as 2 months later, to determine whether they experience positive change, and changes over time.

Interventions

This study tests an expressive writing intervention. Expressive writing is the writing of deep thoughts and feelings about a cancer diagnosis and treatment. Participants engage in 4 writing sessions of 30 minutes duration each, spaced one week apart. Participants are allocated to one of two groups: Intervention group or Waitlist control group. The Intervention group participates in the intervention up to 4 weeks post their final cancer tre

This study tests an expressive writing intervention. Expressive writing is the writing of deep thoughts and feelings about a cancer diagnosis and treatment. Participants engage in 4 writing sessions of 30 minutes duration each, spaced one week apart. Participants are allocated to one of two groups: Intervention group or Waitlist control group. The Intervention group participates in the intervention up to 4 weeks post their final cancer treatment session. The intervention is carried out individually by participants in their own homes, with phone assistance from a research assistant.

Sponsors

Peter MacCallum Cancer Centre
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(a) colon or rectal cancer (Dukes stage A, B or C), (b) completed all cancer treatment within last 4 weeks, (c) can read/write English.

Exclusion criteria

(a) has metastatic disease, (b) has recurrent colorectal cancer, (c) previous cancer diagnosis of any type, (d) psychiatric illness (not related to cancer diagnosis).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026